PET STUDIES OF DOPAMINE RECEPTOR DISTRIBUTION USING [F-18] FLUOROETHYLSPIPERONE - FINDINGS IN DISORDERS RELATED TO THE DOPAMINERGIC SYSTEM

被引:49
作者
WIENHARD, K
COENEN, HH
PAWLIK, G
RUDOLF, J
LAUFER, P
JOVKAR, S
STOCKLIN, G
HEISS, WD
机构
[1] MAX PLANCK INST NEUROL RES, OSTMERHEIMER STR 200, W-5000 COLOGNE 91, GERMANY
[2] FORSCHUNGSZENTRUM JULICH, INST CHEM 1, W-5170 JULICH, GERMANY
关键词
[!sup]18[!/sup]F]fluoroethylspiperone; disorders of dopaminergic system; Dopamine receptors; positron emission tomography;
D O I
10.1007/BF01245042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
PET studies of dopamine D2-receptor binding were performed in thirty patients with various disorders related to the dopaminergic system and in six healthy controls. Uptake of [18F]fluoroethylspiperone in caudate over three hours was analyzed in terms of several indices of receptor binding: caudateto-cerebellum activity ratio, concentration of ligand as percentage of injected dose, caudate-to-blood radioactivity ratio, slope of tracer uptake curves, binding potential, kinetic constants of a three compartment model. In 14 patients brain glucose metabolism was also measured. Data on medicated patients demonstrate that the average values of most of the above parameters indicate the decreased number of available D2-receptors whereby, besides an age dependent decline, the caudate-to-cerebellum ratio affords the relatively best distinction among diagnostic groups. In individual cases, large variability among subjects permits only the classification of severe pathologies. Morphological damage and neuronal loss in the striatum may also cause abnormal low values both for the indices of receptor binding and for glucose consumption, thus providing a possible pathogenetic link between receptor dysfunction and impaired energy metabolism. © 1990 Springer-Verlag.
引用
收藏
页码:195 / 213
页数:19
相关论文
共 35 条
  • [1] LOSS OF STRIATAL [BR-76] BROMOSPIPERONE BINDING-SITES DEMONSTRATED BY POSITRON TOMOGRAPHY IN PROGRESSIVE SUPRANUCLEAR PALSY
    BARON, JC
    MAZIERE, B
    LOCH, C
    CAMBON, H
    SGOUROPOULOS, P
    BONNET, AM
    AGID, Y
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1986, 6 (02) : 131 - 136
  • [2] BLOCK D, 1986, J LABELLED COMPD RAD, V23, P1042
  • [3] [H-3] SPIPERONE BINDING, DOPAMINE AND HVA CONCENTRATIONS IN PARKINSONS-DISEASE AND SUPRANUCLEAR PALSY
    BOKOBZA, B
    RUBERG, M
    SCATTON, B
    JAVOYAGID, F
    AGID, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) : 167 - 175
  • [4] INVIVO [H-3]SPIPERONE BINDING - EVIDENCE FOR ACCUMULATION IN CORPUS STRIATUM BY AGONIST-MEDIATED RECEPTOR INTERNALIZATION
    CHUGANI, DC
    ACKERMANN, RF
    PHELPS, ME
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1988, 8 (03) : 291 - 303
  • [5] COENEN HH, 1988, EUR J NUCL MED, V14, P80
  • [6] 3-N-(2-[F-18]-FLUOROETHYL)-SPIPERONE - A NOVEL LIGAND FOR CEREBRAL DOPAMINE RECEPTOR STUDIES WITH PET
    COENEN, HH
    LAUFER, P
    STOCKLIN, G
    WIENHARD, K
    PAWLIK, G
    BOCHERSCHWARZ, HG
    HEISS, WD
    [J]. LIFE SCIENCES, 1987, 40 (01) : 81 - 88
  • [7] FARDE L, 1987, ARCH GEN PSYCHIAT, V44, P671
  • [8] FARDE L, 1987, CLIN EFFICACY POSITR, P213
  • [9] FOWLER JS, 1982, J NUCL MED, V23, P437
  • [10] CENTRAL DOPAMINERGIC PATHWAYS IN HEMIPARKINSONISM EXAMINED BY POSITRON EMISSION TOMOGRAPHY
    GARNETT, ES
    NAHMIAS, C
    FIRNAU, G
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) : 174 - 179